A detailed history of Charles Schwab Investment Management Inc transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 291,876 shares of TBPH stock, worth $2.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
291,876
Previous 291,266 0.21%
Holding current value
$2.86 Million
Previous $2.47 Million 4.74%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$7.66 - $10.25 $4,672 - $6,252
610 Added 0.21%
291,876 $2.35 Million
Q2 2024

Aug 12, 2024

SELL
$8.29 - $9.92 $159,458 - $190,811
-19,235 Reduced 6.19%
291,266 $2.47 Million
Q1 2024

May 08, 2024

SELL
$8.22 - $11.59 $28,852 - $40,680
-3,510 Reduced 1.12%
310,501 $2.79 Million
Q4 2023

Feb 06, 2024

SELL
$8.58 - $11.4 $121,544 - $161,492
-14,166 Reduced 4.32%
314,011 $3.53 Million
Q3 2023

Nov 08, 2023

SELL
$8.38 - $10.44 $630,863 - $785,944
-75,282 Reduced 18.66%
328,177 $2.83 Million
Q2 2023

Aug 09, 2023

SELL
$10.16 - $11.92 $806,836 - $946,602
-79,413 Reduced 16.45%
403,459 $4.18 Million
Q1 2023

May 11, 2023

SELL
$9.87 - $11.44 $330,802 - $383,423
-33,516 Reduced 6.49%
482,872 $5.24 Million
Q4 2022

Feb 13, 2023

SELL
$9.65 - $11.34 $82,295 - $96,707
-8,528 Reduced 1.62%
516,388 $5.79 Million
Q3 2022

Nov 14, 2022

BUY
$8.39 - $10.22 $179,873 - $219,106
21,439 Added 4.26%
524,916 $5.32 Million
Q2 2022

Aug 15, 2022

BUY
$8.41 - $10.34 $848,039 - $1.04 Million
100,837 Added 25.04%
503,477 $4.56 Million
Q1 2022

May 13, 2022

BUY
$8.33 - $12.96 $100,751 - $156,751
12,095 Added 3.1%
402,640 $3.85 Million
Q4 2021

Feb 11, 2022

BUY
$7.42 - $11.05 $287,539 - $428,209
38,752 Added 11.02%
390,545 $4.32 Million
Q3 2021

Nov 16, 2021

SELL
$6.77 - $14.41 $32,164 - $68,461
-4,751 Reduced 1.33%
351,793 $2.6 Million
Q2 2021

Aug 16, 2021

BUY
$14.52 - $22.46 $334,831 - $517,927
23,060 Added 6.91%
356,544 $5.18 Million
Q1 2021

May 17, 2021

BUY
$16.57 - $21.08 $164,142 - $208,818
9,906 Added 3.06%
333,484 $6.81 Million
Q4 2020

Feb 16, 2021

BUY
$14.89 - $20.16 $149,108 - $201,882
10,014 Added 3.19%
323,578 $5.75 Million
Q3 2020

Nov 13, 2020

SELL
$14.79 - $22.49 $9,554 - $14,528
-646 Reduced 0.21%
313,564 $4.64 Million
Q2 2020

Aug 14, 2020

BUY
$20.64 - $30.69 $302,045 - $449,117
14,634 Added 4.88%
314,210 $6.6 Million
Q1 2020

May 15, 2020

BUY
$17.84 - $31.21 $561,531 - $982,365
31,476 Added 11.74%
299,576 $6.92 Million
Q4 2019

Feb 07, 2020

BUY
$16.12 - $25.89 $148,900 - $239,145
9,237 Added 3.57%
268,100 $6.94 Million
Q3 2019

Nov 08, 2019

BUY
$16.51 - $23.78 $113,407 - $163,344
6,869 Added 2.73%
258,863 $5.04 Million
Q2 2019

Aug 09, 2019

BUY
$15.6 - $25.15 $203,455 - $328,006
13,042 Added 5.46%
251,994 $4.12 Million
Q1 2019

May 14, 2019

BUY
$22.57 - $28.15 $91,859 - $114,570
4,070 Added 1.73%
238,952 $5.42 Million
Q4 2018

Feb 14, 2019

SELL
$22.52 - $35.07 $44,544 - $69,368
-1,978 Reduced 0.84%
234,882 $6.01 Million
Q3 2018

Nov 13, 2018

BUY
$22.83 - $32.67 $241,815 - $346,040
10,592 Added 4.68%
236,860 $7.74 Million
Q2 2018

Aug 08, 2018

BUY
$22.06 - $25.52 $379,277 - $438,765
17,193 Added 8.22%
226,268 $5.13 Million
Q1 2018

May 07, 2018

BUY
$23.37 - $29.71 $219,631 - $279,214
9,398 Added 4.71%
209,075 $5.07 Million
Q4 2017

Jan 17, 2018

BUY
$25.82 - $35.66 $209,632 - $289,523
8,119 Added 4.24%
199,677 $5.57 Million
Q3 2017

Nov 13, 2017

BUY
$23.88 - $34.96 $4.57 Million - $6.7 Million
191,558
191,558 $6.56 Million

Others Institutions Holding TBPH

About Theravance Biopharma, Inc.


  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $654M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.